Delivery Order SPE2DB20D3101-SPE2DB24FRRL2

Award Date 8/2/24
Potential Completion Date 8/5/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,402.97 firm fixed-price delivery order is for the supply of 4564616857 - ROCURONIUM 50 MG/5 ML VIAL 5ML. The contract has a completion date of May 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, as the prime contractor. The contract, a firm fixed price delivery order worth $2,035.24, is for the supply of 4564158471 ROCURONIUM 50 MG/5 ML VIAL 5ML to support military treatment programs and facilities. The contract has an ultimate completion date of April 4, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,054.31, is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999 and running through November 2026. The contract covers the delivery of 4566633061 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical product, to support military...
This federal contract award to AmerisourceBergen Drug Corp provides for the delivery of 4566703854 - ROCURONIUM 50 MG/5 ML VIAL 5ML, a critical medical commodity used in healthcare settings. The firm-fixed-price contract, valued at $1,176.78, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a division of the Department of Defense that procures medical supplies and equipment for military treatment facilities and other federal healthcare programs. The contract has an...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,558,029,625 units of the drug Rocuronium 50 mg/5 ml vial with a 5 ml volume. The $1,097.76 firm fixed price delivery order has an ultimate completion date of August 9, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves as a primary vehicle...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4566690469 - Rocuronium 100 mg/10 ml vial, 10 ml. The contract has a ceiling value of $2,089.12 and is a Firm Fixed Price Delivery Order contract type. The ultimate completion date is December 12, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,003.66 firm fixed-price delivery order is for the supply of 4,566,133,818 units of Rocuronium 50 mg/5 ml vial, a critical medical product used in healthcare settings. The award is not designated with a set-aside and represents an open competition. It is part of a larger $999,999,999 Indefinite Delivery Contract...
This is a $1,105.56 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4567367457 ROCURONIUM 100 MG/10 ML VIAL 10ML, a critical medical commodity, to support federal healthcare programs. The award is part of AmerisourceBergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award, valued at $1,105.56, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of 4,566,688,720 units of the pharmaceutical product Rocuronium 100 mg/10 ml vial, a critical medication used in healthcare settings. The contract has a ceiling value of $1,105.56 and an ultimate completion date of December 12, 2024. It is structured as a Firm Fixed Price Delivery Order, with...
This federal contract award is a delivery order issued to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a firm fixed price of $21,691.18 and a period of performance through November 5, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products...
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB24FRRL2
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen), a major pharmaceutical distributor, involves the delivery of 4565332483 - ROCURONIUM 50 MG/5 ML VIAL 5ML to the Defense Logistics Agency (DLA). The firm-fixed-price Delivery Order, valued at $1,846.80, has an ultimate completion date of August 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This award is not designated as a set-aside contract. The contract supports the healthcare needs of military personnel, veterans, and other federal beneficiaries through a streamlined, comprehensive contracting mechanism.

Generated 2/27/25, 9:44 AM